142 related articles for article (PubMed ID: 12206622)
1. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy.
Polak F; Morton R; Ward C; Wallace WA; Doderlein L; Siebel A
Dev Med Child Neurol; 2002 Aug; 44(8):551-5. PubMed ID: 12206622
[TBL] [Abstract][Full Text] [Related]
2. Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy.
Bang MS; Chung SG; Kim SB; Kim SJ
Am J Phys Med Rehabil; 2002 Oct; 81(10):760-4. PubMed ID: 12362116
[TBL] [Abstract][Full Text] [Related]
3. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
Bottos M; Benedetti MG; Salucci P; Gasparroni V; Giannini S
Dev Med Child Neurol; 2003 Nov; 45(11):758-62. PubMed ID: 14580131
[TBL] [Abstract][Full Text] [Related]
5. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.
Willis AW; Crowner B; Brunstrom JE; Kissel A; Racette BA
Dev Med Child Neurol; 2007 Nov; 49(11):818-22. PubMed ID: 17979859
[TBL] [Abstract][Full Text] [Related]
6. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
7. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy.
Sutherland DH; Kaufman KR; Wyatt MP; Chambers HG; Mubarak SJ
Gait Posture; 1999 Sep; 10(1):1-9. PubMed ID: 10469936
[TBL] [Abstract][Full Text] [Related]
8. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
Franzén M; Hägglund G; Alriksson-Schmidt A
BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
[TBL] [Abstract][Full Text] [Related]
11. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
[TBL] [Abstract][Full Text] [Related]
12. Effect of botulinum toxin type A treatment in children with cerebral palsy: Sequential physical changes for 3 months after the injection.
Matsuda M; Tomita K; Yozu A; Nakayama T; Nakayama J; Ohguro H; Iwasaki N
Brain Dev; 2018 Jun; 40(6):452-457. PubMed ID: 29510955
[TBL] [Abstract][Full Text] [Related]
13. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
[TBL] [Abstract][Full Text] [Related]
17. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
[TBL] [Abstract][Full Text] [Related]
19. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy.
Boyd RN; Pliatsios V; Starr R; Wolfe R; Graham HK
Dev Med Child Neurol; 2000 Jan; 42(1):32-41. PubMed ID: 10665973
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy.
Dursun N; Bonikowski M; Dabrowski E; Matthews D; Gormley M; Tilton A; Carranza J; Grandoulier AS; Picaut P; Delgado MR
Dev Neurorehabil; 2020 Aug; 23(6):368-374. PubMed ID: 31691605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
